cancer of brain and nervous system	is a	cancer
cancer of brain and nervous system	is a	malignant neoplasm
cancer of brain and nervous system	is a	brain tumor
cancer of brain and nervous system	treated with	radiotherapy
cancer of brain and nervous system	treated with	chemotherapy
cancer of brain and nervous system	treated with	surgical resection
cancer of brain and nervous system	treated with	neurosurgery
cancer of brain and nervous system	treated with	temozolomide
cancer of brain and nervous system	diagnosed by	MRI
cancer of brain and nervous system	diagnosed by	CT scan
cancer of brain and nervous system	diagnosed by	biopsy
cancer of brain and nervous system	diagnosed by	histology
cancer of brain and nervous system	diagnosed by	CSF cytology
cancer of brain and nervous system	includes subtype	glioblastoma
cancer of brain and nervous system	includes subtype	astrocytoma
cancer of brain and nervous system	includes subtype	oligodendroglioma
cancer of brain and nervous system	includes subtype	meningioma
cancer of brain and nervous system	includes subtype	medulloblastoma
cancer of brain and nervous system	has molecular feature	MGMT methylation
cancer of brain and nervous system	has molecular feature	IDH mutation
cancer of brain and nervous system	has amplification	EGFR amplification
cancer of brain and nervous system	has mutation	TP53 mutation
cancer of brain and nervous system	has mutation	BRAF mutation
cancer of brain and nervous system	associated with	edema
cancer of brain and nervous system	associated with	mass effect
cancer of brain and nervous system	associated with	intracranial hypertension
cancer of brain and nervous system	presents with	headache
cancer of brain and nervous system	presents with	seizure
cancer of brain and nervous system	presents with	focal deficit
cancer of brain and nervous system	presents with	nausea
cancer of brain and nervous system	presents with	vomiting
cancer of brain and nervous system	presents with	cognitive impairment
cancer of brain and nervous system	prognostic factor	MGMT methylation
cancer of brain and nervous system	prognostic factor	IDH mutation
cancer of brain and nervous system	prognosis	poor
cancer of brain and nervous system	prognosis	better with IDH mutation
cancer of brain and nervous system	prognosis	variable by subtype
cancer of brain and nervous system	monitored by	MRI
cancer of brain and nervous system	monitored by	CT
cancer of brain and nervous system	monitored by	PET
cancer of brain and nervous system	therapy goal	palliation
cancer of brain and nervous system	therapy goal	disease control
cancer of brain and nervous system	response to therapy	radiographic response
cancer of brain and nervous system	response to therapy	clinical improvement
cancer of brain and nervous system	side effect	hair loss
cancer of brain and nervous system	side effect	fatigue
cancer of brain and nervous system	side effect	cognitive changes
cancer of brain and nervous system	recurrence	relapse
cancer of brain and nervous system	recurrence pattern	local
cancer of brain and nervous system	recurrence pattern	distant
cancer of brain and nervous system	biopsy result	glioblastoma
cancer of brain and nervous system	biopsy result	oligodendroglioma
cancer of brain and nervous system	histology	glioblastoma
cancer of brain and nervous system	histology	astrocytoma
cancer of brain and nervous system	histology	oligodendroglioma
cancer of brain and nervous system	therapy	radiotherapy
cancer of brain and nervous system	therapy	chemotherapy
cancer of brain and nervous system	therapy	temozolomide
cancer of brain and nervous system	guidelines	NCCN
cancer of brain and nervous system	coding	ICD-10-CM
cancer of brain and nervous system	incidence	age groups
cancer of brain and nervous system	risk factor	radiation exposure
cancer of brain and nervous system	risk factor	family history
cancer of brain and nervous system	clinical feature	papilledema
cancer of brain and nervous system	clinical feature	personality change
cancer of brain and nervous system	clinical feature	visual disturbance
cancer of brain and nervous system	prognosis modifier	age
cancer of brain and nervous system	prognosis modifier	performance status
cancer of brain and nervous system	economic impact	cost burden
cancer of brain and nervous system	caregiver impact	burden
cancer of brain and nervous system	research area	neuro-oncology
cancer of brain and nervous system	rare tumor	craniopharyngioma
cancer of brain and nervous system	rare tumor	ependymoma
cancer of brain and nervous system	rare tumor	ependymal tumor
cancer of brain and nervous system	imaging characteristic	ring-enhancing lesion
cancer of brain and nervous system	imaging characteristic	necrosis
cancer of brain and nervous system	imaging characteristic	edema
cancer of brain and nervous system	follow-up modality	MRI
cancer of brain and nervous system	follow-up modality	CT
cancer of brain and nervous system	follow-up modality	PET-CT
cancer of brain and nervous system	imaging marker	perfusion
cancer of brain and nervous system	imaging marker	diffusion restriction
cancer of brain and nervous system	biomarker	MGMT methylation
cancer of brain and nervous system	biomarker	IDH mutation
cancer of brain and nervous system	biomarker	EGFR amplification
cancer of brain and nervous system	social impact	stigma
cancer of brain and nervous system	disability	neurological disability
cancer of brain and nervous system	complication	hydrocephalus
cancer of brain and nervous system	complication	edema reduction
cancer of brain and nervous system	burden	healthcare costs
cancer of brain and nervous system	patient education	counseling
cancer of brain and nervous system	rare tumor	medulloblastoma
